Navigation Links
Signalife Announces Reverse Stock Split, Preferred Stock Dividend and $5 Million Investment
Date:9/10/2008

common stock. It is believed that a significant reduction in the company's public float will reduce or minimize the ability of illegal short sellers to manipulate the market price of the common stock. To address this situation, Signalife has engaged lawyers nationwide in order to assure that every naked short sale (4 days of non-delivery after sale) will be answered instantaneously by a lawsuit in the jurisdiction relevant to the brokerage house. If short sellers wish to get sued, and subject themselves to discovery, every four days, we have lawyers who will oblige them on contingency bases and will move for injunctive relief immediately. The only exceptions will be those persons who unilaterally send a letter to the company that outlines who they are, that they are making a market in the securities, and that they are not conducting any long-term short selling more than 13 days (the SHO threshold list). These must be in writing in order to avoid being sued. Because there will be less than 100,000 shares outstanding after the reverse split, it will be extremely easy for the company's lawyers to track the naked short sales and the company has engaged several service providers who access SEC information to confirm such facts." Signalife reserves the right to not sue anybody who it reasonably believes -- in its own discretion -- is innocent of "mens rea" and Signalife reasonably believes acted without "scienter."

Signalife further announced that Signalife's principal shareholder, ARC Finance Group, LLC, and certain of the company's directors, have each entered into a private placement with the company pursuant to which they agreed to invest a total of $5 million on the first business day after the full implementation of the reverse stock split with the Delaware Secretary of State. Under the terms of the private placement, the investors will purchase a new series of convertible preferred stock, to be designated series 'B', and will be entitled to a number of such
'/>"/>

SOURCE Signalife, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related biology technology :

1. Signalife Announces Anticipated Date of Transition to OTCBB
2. Signalife to Issue Breaking News Regarding Vianale & Vianale Tomorrow
3. Signalife Announces Intent to Withdraw From AMEX and Trade on the OTCBB
4. AFL To Return to Oklahoma Due to Overwhelming Demand for Signalife Heart Screening
5. Signalife Board Approves Merger
6. Signalife Announces AFL Joins NIH Education Program
7. Signalife Appoints Lee Ehrlichman President and Chief Operating Officer
8. Signalife Appoints Lee Ehrlichman as Company Director and Operations Director; Additional Notice Received From Amex Regarding Sharholders Equity Deficiency
9. Signalife Awarded New U.S. Patent, System For, And Method Of, Monitoring Heartbeats Of A Patient
10. Signalife Announces Webcast
11. AMEX Notifies Signalife That It Has Accepted Signalifes Plan of Compliance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2015)... July 29, 2015 US-Australian drug discovery company, ... confirmed it is committed to progressing its ground-breaking technology ... practicable and to ensure the Company delivers the best ... Iain Ross , said the Company currently had ... pre-clinical programs, discovery programs and academic partnerships and initiatives, ...
(Date:7/29/2015)...  HealthSouth Corporation (NYSE: HLS ), one ... services, offering both facility-based and home-based post-acute services, ... second quarter ended June 30, 2015. ... growth in both segments and an 11.0% increase ... and Chief Executive Officer of HealthSouth. "While reported ...
(Date:7/29/2015)... , July 29, 2015 ... announced the addition of the "Global Biosimilars ... offering. The Global Biosimilars Market, 2015 ... the rapidly growing biosimilars market. With the blockbuster ... to minimize costs, biosimilars are being viewed as ...
(Date:7/29/2015)... 2015  Therapath Neuropathology ( www.Therapath.com ), a ... VA and Military Medical centers both domestically and ... and Sweat Gland Nerve Fiber Density (SGNFD) for ... ). Demonstration of a reduction ... punch skin biopsy is a highly sensitive and ...
Breaking Biology Technology:Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 2Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 3Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 4Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 5Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 6Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 7Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 8Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 9Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 10HealthSouth Reports Results for Second Quarter 2015 2HealthSouth Reports Results for Second Quarter 2015 3HealthSouth Reports Results for Second Quarter 2015 4HealthSouth Reports Results for Second Quarter 2015 5HealthSouth Reports Results for Second Quarter 2015 6HealthSouth Reports Results for Second Quarter 2015 7HealthSouth Reports Results for Second Quarter 2015 8HealthSouth Reports Results for Second Quarter 2015 9HealthSouth Reports Results for Second Quarter 2015 10HealthSouth Reports Results for Second Quarter 2015 11HealthSouth Reports Results for Second Quarter 2015 12HealthSouth Reports Results for Second Quarter 2015 13HealthSouth Reports Results for Second Quarter 2015 14HealthSouth Reports Results for Second Quarter 2015 15HealthSouth Reports Results for Second Quarter 2015 16HealthSouth Reports Results for Second Quarter 2015 17HealthSouth Reports Results for Second Quarter 2015 18HealthSouth Reports Results for Second Quarter 2015 19HealthSouth Reports Results for Second Quarter 2015 20HealthSouth Reports Results for Second Quarter 2015 21HealthSouth Reports Results for Second Quarter 2015 22HealthSouth Reports Results for Second Quarter 2015 23HealthSouth Reports Results for Second Quarter 2015 24HealthSouth Reports Results for Second Quarter 2015 25HealthSouth Reports Results for Second Quarter 2015 26HealthSouth Reports Results for Second Quarter 2015 27
... Gen-Probe Incorporated,(Nasdaq: GPRO ) announced today that ... and chief operating officer, effective March 1, 2008., ... of 2007 as executive vice,president and chief operating ... research and development, manufacturing, and,sales and marketing., ...
... be held on Thursday, February 21, 2008 at 5:00 ... (Eastern) / 9:00 pm (Beijing/Hong Kong), SHENYANG, China, ... biotechnology company focused on researching,developing, manufacturing and marketing biopharmaceutical ... for the fourth,quarter and full year ended December 31, ...
... Products,Corp. (OTC Bulletin Board: TKER), a manufacturer and ... today,reported that it has installed its equipment to ... new plant operated by one of the,top 10 ... test of the,application to gauge its effectiveness, during ...
Cached Biology Technology:Carl Hull Named President and Chief Operating Officer of Gen-Probe 2Carl Hull Named President and Chief Operating Officer of Gen-Probe 33SBio Inc. Schedules 2007 Fourth Quarter and Full Year Earnings Release on Wednesday, February 20, 2008 2Tasker Products Installs Scalder Application at New Poultry Processor's Facility 2Tasker Products Installs Scalder Application at New Poultry Processor's Facility 3
(Date:7/31/2015)... de julio de 2015 BGI llevará a cabo ... del 22 al 25 de octubre de 2015, en ... conferencia celebra su décimo aniversario este año. Desde su ... de las reuniones anuales más influyentes del mundo en ... las conferencias científicas más dinámicas, entusiastas y amenas. ...
(Date:7/31/2015)... , 31. Juli 2015 Die 10. internationale Konferenz ... BGI veranstaltet und findet vom 22. bis 25. ... , statt. Die Konferenz feiert ... Start 2006 ist die ICG weltweit zu einem ... Sie ist eines der dynamischsten, enthusiastischsten und angenehmsten ...
(Date:7/27/2015)... Calif. , July 27, 2015  Synaptics ... of human interface solutions, today announced that Huawei ... touchscreen solution for its stylish smartwatch. Huawei ... its proven reliability, low power and highly responsive ... wet finger. Huawei designers also required a classic ...
Breaking Biology News(10 mins):La 10ª Conferencia Internacional sobre Genómica (ICG-10) comienza en octubre 2La 10ª Conferencia Internacional sobre Genómica (ICG-10) comienza en octubre 3Die 10. internationale Konferenz zu Genomik (ICG-10) beginnt im Oktober 2Die 10. internationale Konferenz zu Genomik (ICG-10) beginnt im Oktober 3Synaptics Touchscreen Solution Powers New Huawei Watch 2Synaptics Touchscreen Solution Powers New Huawei Watch 3
... molecular mechanism in the liver that explains, for the ... and trans-fatty acids causes elevated blood levels of cholesterol ... and certain cancers. , In the Jan. 28 issue ... that the harmful effects of saturated and trans fats ...
... treated with radical mastectomy and adjuvant chemotherapy, the addition ... few long-term toxic effects, according to a 20-year follow-up ... 19 issue of the Journal of the National Cancer ... was designed to determine the effect on survival of ...
... a recent U.S. study, investigators in Japan found no ... form of high blood pressure, as reported in the ... now available online. , The researchers reported that they ... also known as the Kaposi's sarcoma virus, in the ...
Cached Biology News:Scientists ID molecular 'switch' in liver that triggers harmful effects of saturated and trans fats 2Scientists ID molecular 'switch' in liver that triggers harmful effects of saturated and trans fats 3Novel Asthma Study Shows Multiple Genetic Input Required; Single-gene Solution Shot Down 2Association of herpesvirus with lung disorder questioned 2
...
Rubeola (Measles) Antigen Preservative: No Preservatives...
One-step, microplate or cuvet, colorimetric, linear detection range 8 mg/dL to 300 mg/dL. Procedure: 5 min....
Homo sapiens jumping translocation breakpoint...
Biology Products: